Table 3.
Univariate Analysis | Multivariate Analysis | |||||||
---|---|---|---|---|---|---|---|---|
Variable | Hazard Ratio | 95% CI | p-Value | Hazard Ratio | 95% CI | p-Value | ||
Male | 1.551 | 0.854 | 2.816 | 0.149 | 1.597 | 0.875 | 2.915 | 0.127 |
Age > 60 years | 2.634 | 1.360 | 5.101 | 0.004 | 2.630 | 1.352 | 5.118 | 0.004 |
Diabetes | 1.909 | 1.051 | 3.465 | 0.034 | 1.916 | 1.053 | 3.485 | 0.033 |
Hypertension | 1.192 | 0.427 | 3.328 | 0.737 | ||||
Heart failure | 1.315 | 0.634 | 2.731 | 0.462 | ||||
Vascular access (fistula) | 1.415 | 0.768 | 2.604 | 0.265 | ||||
Residual diuresis | 0.819 | 0.430 | 1.561 | 0.545 | ||||
Hemodialysis vintage | 1.004 | 0.991 | 1.017 | 0.568 | ||||
Dry weight | 0.973 | 0.938 | 1.008 | 0.128 | 0.981 | 0.946 | 1.017 | 0.301 |
spKt/V | 1.904 | 0.469 | 7.738 | 0.368 | ||||
Use of ARBs | 1.076 | 0.556 | 2.083 | 0.829 | ||||
Use of CCBs | 0.798 | 0.424 | 1.500 | 0.483 | ||||
Use of loop diuretics | 1.387 | 0.702 | 2.737 | 0.346 | ||||
Use of vitamin D analogs | 0.959 | 0.475 | 1.938 | 0.908 | ||||
Use of phosphate binders | 1.073 | 0.454 | 2.534 | 0.873 | ||||
Use of calcimimetics | 0.899 | 0.419 | 1.931 | 0.786 | ||||
Use of ESAs | 0.840 | 0.391 | 1.803 | 0.654 | ||||
Blood ureic nitrogen | 0.987 | 0.963 | 1.010 | 0.261 | ||||
Intact PTH | 1.000 | 0.999 | 1.000 | 0.420 | ||||
25-OH vitamin D | 0.982 | 0.948 | 1.016 | 0.295 | ||||
Serum phosphate | 0.941 | 0.722 | 1.226 | 0.654 | ||||
Total serum calcium | 1.060 | 0.789 | 1.425 | 0.697 | ||||
Ferritin | 1.000 | 0.999 | 1.002 | 0.580 | ||||
Hemoglobin | 1.091 | 0.884 | 1.347 | 0.418 | ||||
Intact FGF23 (>p50) | 1.917 | 1.041 | 3.530 | 0.037 | 1.920 | 1.035 | 3.562 | 0.039 |